Analyst Actions -- 10/24/2011

 | Oct 24, 2011 | 8:03 AM EDT  | Comments
  • Comment
  • Print Print
  • Print
Stock quotes in this article:

lly

,

sks

,

sti

,

xrx

,

slb

Abbott Laboratories target raised at UBS

ABT target increased to $60, UBS said.  See company split as value creating.  Maintain Buy rating.

-----

Agilent Technologies rated new Buy at UBS

A was initiated with a Buy rating, UBS said.  $43 price target.  Portfolio transformation is underappreciated.

-----

BB&T estimates, target increased at Citigroup

Shares of BBT now seen reaching $24, according to Citigroup.  Estimates also raised as NIM outlook reduced and appears reasonable.  Neutral rating. 

-----

City National numbers reduced at Jefferies

CYN estimates were cut through 2012, Jefferies said. Company is seeing lower core earnings growth. Hold rating and new $41 price target.

-----

Cohen & Steers numbers cut at Goldman

CNS estimates were reduced through 2013, Goldman Sachs said. Company is realizing lower asset flows. Neutral rating and new $24 price target.

-----

CVS Caremark numbers raised at Citigroup
Shares of CVS now seen reaching $45, according to Citigroup.  Estimates also increased on strong SSS.  Maintain Buy rating.

-----

Dover estimates, target cut at Credit Suisse

Shares of DOV now seen reaching $65, according to Credit Suisse. Estimates also reduced, given slower electronic technology demand. Neutral rating.

-----

Eli Lilly numbers cut at Jefferies

Shares of LLY now seen reaching $33, according to Jefferies. Estimates also reduced, given margin pressures. Hold rating.

-----

General Electric estimates, target cut at Citigroup

Shares of GE now seen reaching $19, according to Citigroup.  Estimates also lowered as pricing and margin headwinds are lingering longer than expected.

-----

Home Depot estimates, target increased at Citigroup

Shares of HD now seen reaching $44, according to Citigroup.  Estimates also raised as supply chain / technology initiatives provide significant runway for OM expansion. 

-----

Honeywell International numbers increased at Citigroup

Shares of HON now seen reaching $55, according to Citigroup.  Estimates also increased on strong 3Q and positioning for 2012.  Neutral rating.

-----

Idacorp downgraded at Wells

IDA was downgraded from Outperform to Market Perform, Wells Fargo said. Valuation call.

-----

Kansas City Southern numbers boosted at Credit Suisse

Shares of KSU now seen reaching $70, according to Credit Suisse. Estimates also upped, given the company's new business opportunities. Outperform rating.

-----

Lowe's numbers adjusted at Citigroup

Shares of LOW now seen reaching $23, according to Citigroup.  Estimates lowered on continued underperformance versus Home Depot.  Neutral rating. 

-----

Noble Energy upgraded at BMO

NBL was upgraded from Market Perform to Outperform, BMO Capital said. Valuation call, based on a $120 price target.  

-----

Nuance Communication estimates, target increased at UBS

Shares of NUAN now seen reaching $29, according to UBS.  Estimates also raised on positive Q4 pre release and convert debt.  Buy rating.

-----

Owens & Minor numbers cut at UBS

Shares of OMI now seen reaching $31, according to UBS.  Estimates also lowered on UBS hospital survey.  Neutral rating.

-----

Petsmart estimates, target raised at Oppenheimer

Shares of PETM now seen reaching $58, according to Oppenheimer. Estimates also increased, as the company continues to deliver solid sales growth. Outperform rating.

-----

Saks upgraded at Deutsche

SKS was upgraded from Sell to Hold, Deutsche Bank said. $9 price target. Sales trends have stabilized.

-----

Schlumberger estimates, target cut at Credit Suisse

SLB estimates were reduced through 2013, Credit Suisse said. Business recovery is proving to be more gradual. Outperform rating and new $99 price target.

-----

Schlumberger estimates, target lowered at UBS

Shares of SLB now seen reaching $95, according to UBS.  Estimates also lowered on near term North American pressure pumping concerns.  Buy rating.

-----

Suntrust Banks numbers lowered at Jefferies

Shares of STI now seen reaching $25, according to Jefferies. Estimates also cut, as the company is seeing higher mortgage costs. Buy rating.

-----

Texas Instruments estimates lowered at UBS

TXN estimates lowered through 2012, UBS said.  Expect in line 3Q with modest downside to 4Q.  Maintain $32 price target and Buy rating.

-----

Verizon estimates lowered at Citigroup

VZ estimates lowered through 2012, Citigroup said.  Solid 3Q normalized wireline margin on a slower revenue recovery. 

-----

Xerox estimates, target reduced at BMO

Shares of XRX now seen reaching $9, according to BMO Capital. Estimates also cut, given lower expected sales. Market Perform rating.

Columnist Conversations

Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Before: Transparency is...
Market gets hit from impact of sanctions against Russia for second day in row but manages to rally a bit to en...
We took out some of the high end of support, but I'm still looking at this symmetrical pullback for entries on...
going into trading today roughly 37 million shares of X (US Steel) was held short.today big X has traded 27 mi...

BEST IDEAS

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.